Company recalls approximately 50 employees to core roles across organization MONCTON, New Brunswick, May 14, 2020–(BUSINESS WIRE)–As it continues to monitor and assess the implications of the COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has announced the […] READ MORE: https://www.newcannabisventures.com/organigram-announces-first-phase-of-return-to-work-strategy/
Both of these stocks are down more than 60% in the past year, but which one is more likely to bounce back? READ MORE: https://finance.yahoo.com/m/ba39c4d3-5824-32e8-8b8d-76f758a7e162/better-buy:-organigram.html?.tsrc=rss
New initiatives include niche and value brand entries, as well as initial production of new form factors MONCTON, New Brunswick, April 23, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide an update related to the […] READ MORE: https://www.newcannabisventures.com/consumer-research-drives-enhancements-to-organigram-adult-recreational-commercial-portfolio/
Organigram Holdings Inc. Announces At-The-Market Equity Program MONCTON, New Brunswick-April 22, 2020-(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX:OGI) (NASDAQ:OGI) announced today that it has established an at-the-market equity program (the “ATM Program”) that allows the Corporation to issue up to C$49,000,000 (or its U.S. dollar equivalent) of common shares (“Common Shares”) from treasury […] READ MORE: https://www.newcannabisventures.com/organigram-establishes-c49-million-at-the-money-equity-program/
Organigram Holdings Inc.’s fiscal second-quarter results missed analyst expectations as the launch of Cannabis 2.0 products resulted in higher costs for the cannabis producer. The Moncton, N.B.-based pot producer said its second-quarter revenue was $23.2 million, down from $26.9 million in the same period a year earlier, and down sequentially from $25.2 million in the previous quarter. The decline in…
Organigram Reports Second Quarter Fiscal 2020 Results Net revenue of $23.2 million compared to $26.9 million in Q2 2019 and $25.2 million in Q1 2020 Adult-use recreational net revenue sequentially grew 16% to $15.0 million from $12.9 million in Q1 2020 Ended quarter with $41.2 million in cash and short-term investments First shipped its […] READ MORE: https://www.newcannabisventures.com/organigram-fiscal-q2-revenue-declines-8-from-q1-to-23-2-million/
MONCTON, New Brunswick–(BUSINESS WIRE)—- $OGI–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its results for the second quarter ended February 29, 2020 (“Q2” or “Q2 2020”). (in 000s) Q2 2020 Q2 2019 % Change Select Key Financial Metrics …
Also provides details for Q2 Fiscal 2020 earnings conference call scheduled for April 14, 2020 MONCTON, New Brunswick, April 6, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced the temporary layoff of approximately 45 per cent of […] READ MORE: https://www.newcannabisventures.com/organigram-provides-update-on-corporate-action-plan-in-response-to-covid-19-pandemic/
MONCTON, New Brunswick, March 23, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has received Health Canada’s approval for the licensing of the remainder of its Phase 5 expansion together with […] READ MORE: https://www.newcannabisventures.com/organigram-receives-health-canada-license-renewal-and-expansion-for-final-elements-of-phase-5-and-provides-covid-19-update/
Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes Survey canvased over 2,000 Canadians on perceptions and attitudes around edible products Results reveal top concerns that may impact purchase decisions, including controlling dosage, tested products and reliable onset/offset time Data to inform Company’s product design and educational programming MONCTON, […] READ MORE: https://www.newcannabisventures.com/organigram-releases-summary-findings-from-cannabis-edibles-research-study/
Paolo De Luca, current CFO, appointed Chief Strategy Officer Derrick West, currently on Board of Directors, joins as Chief Financial Officer MONCTON, New Brunswick, March 04, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that […] READ MORE: https://www.newcannabisventures.com/organigram-expands-leadership-team-with-the-appointment-of-chief-strategy-officer-and-newly-appointed-chief-financial-officer/
Exclusive Interview with Organigram CEO Greg Engel In 2018, Organigram (NASDAQ: OGI) (TSX: OGI) CEO Greg Engel spoke with New Cannabis Ventures about creating a company culture of quality. Two years later, the cannabis operator is differentiating itself through a focus on high-quality production at low costs. Engel checked in with New Cannabis Ventures to […] READ MORE: https://www.newcannabisventures.com/organigram-bets-big-on-chocolate/